Randomised controlled trial of lactulose versus rifaximin for prophylaxis of hepatic encephalopathy in patients with acute variceal bleed

Gut

Volumn 64, Issue 8, 2015, Pages 1341-1342

  Maharshi, Sudhir ^a   Sharma, Barjesh Chander ^a   Srivastava, Siddharth ^a   Jindal, Amit ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOACRYLATE; HEMOGLOBIN; LACTULOSE; RIFAXIMIN; VASOACTIVE AGENT;

ABDOMINAL PAIN; ADULT; BLOATING; BLOOD TRANSFUSION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ESOPHAGUS VARICES BLEEDING; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LENGTH OF STAY; LETTER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH VARICES BLEEDING; LIVER TRANSPLANTATION;

FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER TRANSPLANTATION; MALE;

EID: 84940391787     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-308521     Document Type: Letter

References (7)

1. Ferenci P. Diagnosis of minimal hepatic encephalopathy: still a challenge. Gut 2013;62: 1394.
2. Goldbecker A, Weissenborn K, Hamidi SG, et al. Comparison of the most-favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates. Gut 2013;62:1497-505.
3. Grace ND, Groszmann RJ, Garcia-Tsao G, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998;28:868-80.
4. Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007;46:922-38.
5. Sharma P, Agrawal A, Sharma BC, et al. Prophylaxis of hepatic encephalopathy in acute variceal bleed: A randomized controlled trial of lactulose versus no lactulose. J Gastroenterol Hepatol 2011;26: 996-1003.
6. Eltawil KM, Laryea M, Peltekian K, et al. Rifaximin vs conventional oral therapy for hepatic encephalopathy: A meta-analysis. World J Gastroenterol 2012;18: 767-77.
7. Jiang Q, Jiang XH, Zheng MH, et al. Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis. Eur J Gastroenterol Hepatol 2008;20:1064-70.